Home › Funds › PNC Financial Services › TRDA
PNC Financial Services position in TRDA
ENTRADA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.14K sh
Reported value held$8.35K
Portfolio Weight0.00%
First reportedQ1 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 200 | $2.90K | New |
| Q2 2023 | 200 | $3.03K | Hold |
| Q3 2025 | 1.16K | $6.71K | New |
| Q4 2025 | 1.14K | $11.73K | Reduce |
| Q1 2026 | 1.14K | $14.40K | Hold |
| Q2 2026 | 1.14K | $8.35K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TRDA
- BlackRock Inc 2.58M sh · $19.01M · Q2 2026
- Vanguard Group 1.63M sh · $16.78M · Q4 2025
- Wellington Management Group 954.42K sh · $7.02M · Q2 2026
- Millennium Management 763.96K sh · $5.62M · Q2 2026
- Geode Capital Management 717.43K sh · $5.28M · Q2 2026
- AQR Capital Management 699.54K sh · $5.15M · Q2 2026
- JPMorgan Chase & Co 496.46K sh · $3.83M · Q2 2026
- Citadel Advisors 394.32K sh · $2.90M · Q2 2026
- Northern Trust Corp 309.94K sh · $2.28M · Q2 2026
- Charles Schwab Investment Management 197.14K sh · $1.45M · Q2 2026
- Morgan Stanley 191.65K sh · $1.41M · Q2 2026
- Renaissance Technologies 191.00K sh · $1.41M · Q2 2026